Anti-CLL-1 antibodies and immunoconjugates
US10227412B2 · kind B2 · utility
1Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2017 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Aug 21, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.